These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7413682)

  • 1. [Formulation of sustained release tablets. I. Inert matrices].
    Salomen JL; Doelker E
    Pharm Acta Helv; 1980; 55(7):174-82. PubMed ID: 7413682
    [No Abstract]   [Full Text] [Related]  

  • 2. [Formulation of sustained-release tablets. II. Hydrophilic matrices].
    Buri P; Doelker E
    Pharm Acta Helv; 1980; 55(7-8):189-97. PubMed ID: 7433467
    [No Abstract]   [Full Text] [Related]  

  • 3. [Formulation of slow-release tablets. III. Lipid matrices].
    Doelker E; Buri P
    Pharm Acta Helv; 1981; 56(4-5):111-8. PubMed ID: 7255497
    [No Abstract]   [Full Text] [Related]  

  • 4. Formulation of sustained - release lithium carbonate matrix tablets: influence of hydrophilic materials on the release rate and in vitro-in vivo evaluation.
    Emami J; Tavakoli N; Movahedian A
    J Pharm Pharm Sci; 2004 Nov; 7(3):338-44. PubMed ID: 15576014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and in vitro release of ginkgo biloba extract sustained-release tablets].
    Cui Q; Zhu Y; Cui J
    Zhongguo Zhong Yao Za Zhi; 2009 Aug; 34(15):1910-3. PubMed ID: 19894532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on dissolution in vitro of Zhike Pingchuan sustained-release tablets].
    Li X; Feng Z; Huo W; Li Y; Wang B; Zhu S
    Zhongguo Zhong Yao Za Zhi; 2009 May; 34(10):1216-9. PubMed ID: 19673379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
    Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
    Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled release of theophylline from inert matrices: effect of channeling material on release rate.
    Ghaly ES; Malavé MI; Rivera WJ; Martí A
    P R Health Sci J; 1993 Dec; 12(4):255-8. PubMed ID: 8140202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formula optimization based on neural networksin sustained release tablets.
    Wei X; Liang W
    Pharmazie; 2003 Jul; 58(7):521-2. PubMed ID: 12889541
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets.
    Li FQ; Hu JH; Deng JX; Su H; Xu S; Liu JY
    Int J Pharm; 2006 Nov; 324(2):152-7. PubMed ID: 16837152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation of tetrandrine alginate calcium sustained release gel pellets].
    Ma Y; Li WZ; Chen DW
    Zhong Yao Cai; 2008 Jan; 31(1):131-4. PubMed ID: 18589765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of 4 formulation factors on the release of indomethacin from inert matrices with a Eudragit base].
    Gueurten D
    Pharm Acta Helv; 1984; 59(7):200-4. PubMed ID: 6473479
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preparation of ondansetron hydrochloride sustained-release tablet evaluation of its and drug release behavior in vitro].
    Zhang Y; Huang G; Yu Y; Han J; Yu P
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2006 Jun; 23(3):597-600, 614. PubMed ID: 16856397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advances in the production and control of tablets. XVI. Various types of oral preparations with delayed action].
    Chalabala M; Vitková M
    Cesk Farm; 1976 Mar; 25(2):79-81. PubMed ID: 1277318
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained delivery of captopril from floating matrix tablets.
    Jiménez-Martínez I; Quirino-Barreda T; Villafuerte-Robles L
    Int J Pharm; 2008 Oct; 362(1-2):37-43. PubMed ID: 18588962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New co-polymer zwitterionic matrices for sustained release of verapamil hydrochloride.
    Kostova B; Rachev D
    Acta Pharm; 2007 Dec; 57(4):429-39. PubMed ID: 18165187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two galactomannans and scleroglucan as matrices for drug delivery: preparation and release studies.
    Coviello T; Alhaique F; Dorigo A; Matricardi P; Grassi M
    Eur J Pharm Biopharm; 2007 May; 66(2):200-9. PubMed ID: 17156985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer.
    Ochoa L; Igartua M; Hernández RM; Gascón AR; Pedraz JL
    J Pharm Pharm Sci; 2005 Jun; 8(2):132-40. PubMed ID: 16124924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of floating multi-layer coated tablets based on gas formation.
    Sungthongjeen S; Sriamornsak P; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):255-63. PubMed ID: 17967527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sustained-release tablets: predominant mechanism of release of a tracer from matrices composed of total and partial glycerides].
    Doelker C; Doelker E
    Pharm Acta Helv; 1982; 57(7):189-92. PubMed ID: 7122647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.